Clinical Trials

Inclusion Criteria:

• Adult female patients 18 to 99 years of age.
• Patients with proven breast cancer and nodal metastases referred for staging breast MR within the Department of Radiology.
• Patients who are able and willing to sign the informed consent.
• Negative pregnancy test if subject is of child-bearing age (females of child-bearing potential will be screened for pregnancy using a urine pregnancy test, which will be administered by the unit study coordinator at no cost to the patient).

Exclusion Criteria:

• Minors under 18 years of age.
• Patients unable to provide written informed consent.
• Pregnancy.
• eGFR ≤ 30 (4,5).
• History of prior moderate or severe contrast reaction including unresponsiveness, severe respiratory distress, convulsions, arrhythmia, cardiopulmonary distress, progressive angioedema, laryngeal edema, dyspnea, bronchospasm, symptomatic tachycardia, symptomatic bradycardia, hypotension, hypertensive crisis.
• Any history of premedication prior to iodinated contrast.
• Patients that consent to participation but do not undergo their clinically indicated MR scanning for any reason (e.g., bad IV, infiltration, reaction, change in indication).

Eligibility last updated 8/24/21. Questions regarding updates should be directed to the study team contact.